Jan 10, 2023 / 09:30PM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Perfect. Hello, everyone. Thank you for joining us. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to present Rainer Blair from the Danaher team. Today will be your normal session like the rest of the day, 40 minutes. The first 20 will be focused on the company's presentation, followed by 20 minutes of Q&A.
During Q&A, if you're joining us via webcast, feel free to submit your questions through that Q&A function online. And for those of you in the room, if you have a question, please raise your hand, and we have mic runners throughout the room. So with that, thank you.
Rainer M. Blair - Danaher Corporation - President, CEO & Director
Thank you, Rachel, and then thank you to JPMorgan for hosting us today, and hello to all of you. It's great to see so many of you again in person. And of course, also to those of you that were connected via the webcast. So it's great to be here.
Now before we
Danaher Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot